// Events

Upcoming conferences

LSX World Congress
10-11 May 2022
Steven Powell, Chief Executive Officer, will attend as a speaker.

BioEquity Europe
17-18 May 2022
Steven Powell, Chief Executive Officer, will attend as a speaker.

FlandersBio Knowledge for Growth  
18-19 May 2022
Marina Cools, VP of Clinical Development and Board Member of FlandersBio, will attend.

Berenberg Emerging Biotech Conference
19 May 2022
Mathieu Lane, President and Chief Financial Officer of eTheRNA Inc., will attend.

Next Generation RNA Therapeutics Summit
24-26 May 2022
Phil Challis , VP of Product Development, will attend as a speaker.
David Ricketts, Director of Business Development CDMO, will attend.

BIO International Convention
13-16 June 2022
Mathieu Lane, President and Chief Financial Officer of eTheRNA Inc., and Michael Mulqueen, VP of Business Development, will attend.

The Future Healthcare VB100 Conference 2022
14 June 2022
eTheRNA will provide a company overview presentation.

Past conferences

AngloNordic Life Science
4-5 May 2022
Steven Powell, Chief Executive Officer, spoke as part of the ‘RNA in the Spotlight’ panel on Thursday, 5 May from 1:00pm-1:45pm GMT.

Cell & Gene Meeting
26-27 April 2022
 Tim Van Assche, Director of Business Development and Alliance Management, attended the virtual conference.

LNP Formulation & Process Development Summit Boston, MA, USA
12-14 April 2022
George Dakwar, Senior Scientist of Drug Product Development, attended as a speaker.

David Ricketts, Director of Business Development, CDMO attended.

LNP-RNA Therapeutics Virtual Symposium
6-7 April
Stefaan De Koker, VP of Discovery, attended as speaker.

SVB Leerink Biopharma Private Company Connect  
29-30 March 2022
Virtual. Steven Powell, Chief Executive Officer, and Mathieu Lane, President and Chief Financial Officer of eTheRNA Inc., attended the conference.

BIO-Europe Spring   
28-30 March 2022
Virtual. Michael Mulqueen, VP of Business Development attended the conference.

BioCapital Europe
10 March 2022
In-person. Steven Powell, Chief Executive Officer, gave a company overview presentation on 10 March 2022 at 11.40am CET.15th Annual European Life Sciences CEO Forum

1-2 March 2022
Virtual. Volker Germaschewski, Senior VP of Research and Development, spoke at the, “Advances in Immuno-Oncology Panel,” on Wednesday 2nd March 2022 at 12.50pm CET.

RNA Therapeutics Conference 
9-10 February 2022
Volker Germaschewski, Senior VP of Research and Development, spoke about, “Engineering the Future of mRNA Therapies,” on Thursday 10 February 2022 from 12:40-1:00 pm CET.

Phil Challis, VP of Product Development, also attended the conference.

mRNA-Based Therapeutic Summit Europe – Digital
25-27 January 2022
Volker Germaschewski, Vice President of Research and Development, presented about, “Engineering the Future of mRNA Therapies,” on Wednesday 26 January 2022 from 1:00-1:15 pm CET.

Biotech Showcase
10-12 January 2022
Steven Powell, Chief Executive Officer, and Mathieu Lane, Chief Financial Officer of eTheRNA Inc., will be in attendance.

Kempen Life Sciences Crossover Conference
6 January 2022
Steven Powell, Chief Executive Officer, and Mathieu Lane, Chief Financial Officer of eTheRNA Inc., will be in attendance.

BioFIT Digital
7-9 December 2021
Tim Van Assche, Director of Business Development and Alliance Management attended the conference.

ESMO Immuno-Oncology Online Congress
8-11 December 2021
Marina Cools, VP of Clinical Development attended the conference.

The Antwerp Forum – Linking Business between China and Europe
30 November 2021
Bernard Sagaert, COO and VP of Manufacturing, spoke as part of the ‘Current challenges for doing business with China and how to move towards resilient and sustainable post-pandemic times’ panel on Tuesday 30th November 2021 from 10:50am-12:00pm CET.

Jeffries London Healthcare Conference
16-19 November 2021
Mathieu Lane, Chief Financial Officer and President of eTheRNA immunotherapies Inc., attended the conference.

8th China Healthcare Summit
16-19 November 2021
Steven Powell, CEO, spoke on behalf of eTheRNA immunotherapies.

9th International mRNA Health Conference

9-10 November 2021
Stefaan De Koker, VP of Discovery, spoke about, “Cancer vaccines candidates based on optimised mRNA-LNP formulations tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells,” on Wednesday 10th November 2021 from 11:15-11:35 am CET. 

Sonja Van Meirvenne, Principal Scientist Product Development, were in attendance. 

TIDES Europe Oligonucleotides & Peptide Therapeutics
15- 17 November
George Dakwar, Senior Scientist Drug Product Development, and David Ricketts, Director of Business Development, were in attendance.

European Mediscience Awards
16 November 2021
eTheRNA has been shortlisted in the ‘Emerging Star Award’ category. Steven Powell, CEO, and Johanna Madero, Communications Coordinator, attended the awards ceremony.

Biologics Contract Manufacturing Europe
27-28 October 2021
Bernard Sagaert, COO and SVP of Manufacturing, spoke as part of the ‘GMP Manufacturing Requirements and Processes’ panel on Thursday 28th October 2021, from 9:00am-9:30am CET.

David Ricketts, Director of Business Development, attended the conference.

3rd CRIG Industrial Partnering Event

23 October 2021
Stefaan De Koker, VP of Discovery, and Tim Van Assche, Director of Business Development were in attendance and hosted a booth.

Bio-Europe
25-28 October 2021
Michael Mulqueen, VP of Business Development, Tim Van Assche, Director of Business Development and Alliance Management and David Ricketts, Director of Business Development, were in attendance.

Access Biotech China
14-15 October 2021
Steven Powell, Chief Executive Officer, spoke as part of the ‘Partnering with Chinese Companies and/or Investors’ panel, on Thursday, 14 October from 9:00am-10:30am CET.

Tim Van Assche, Director of Business Development attended the conference.

Immunity for Health 2021 – Flanders Vaccine
14 October 2021
Filipe Branco Madeira, Senior Scientist Discovery attended the conference.

Webinar: Hong Kong and Shenzhen Twin Cities in the Greater Bay Area
13 October 2021
Steven Powell, CEO, spoke about eTheRNA’s activities and expansion plans in Hong Kong.

Korea Trade-Investment Promotion Agency Event
8 Oct 2021
Michael Mulqueen, VP of Business Development, spoke as part of the ‘Ways of Cooperation between European and Korean Vaccine Industry’ panel on Friday, 8 October from 10:55am-11:30pm CET.

Steven Powell, Chief Executive Officer attended the conference.

AACR Virtual Conference on Tumour Immunology and Immunotherapy
5-6 October, 2021
Anna Kuchmiy, Discovery Scientist attended the conference.

Optimum Healthcare Investor Conference
4 October 2021
Mathieu Lane, Chief Financial Officer, and President of eTheRNA Inc. attended the conference.

FlandersBio – Knowledge for Growth
27–29 September 2021
Michael Mulqueen, VP of Business Development spoke as part of the ‘The Power of Cell & Gene- Personalised Medicine’ panel on Tuesday, 28 September from 11:00am-12:00pm CET.

Marina Cools, VP of Clinical Development and Board Member of FlandersBio, Tim Van Assche, Director of Business Development and Alliance Management, and Johanna Madero, Communications Coordinator attended the conference.

On Helix
5-6 July 2021
Steven Powell, CEO presented as panelist at, “mRNA Beyond Vaccine,” a panel discussion with key developers of mRNA technologies reviewing the technology acceleration, recent development and impact on other therapeutic areas.

Belfius and Kepler Cheuvreux Digital Life Science Days
21-22 June 2021
Steven Powell, CEO presented on the Company, on Tuesday 22nd June 2021.

Informa Industry Experts Panel
9 June 2021
Steven Powell, CEO attended ‘Designing the Deal’ panel, on Wednesday 9th June 2021 at 1pm CET.

Flanders Vaccine General Assembly
27 May 2021
Marina Cools, VP of Clinical Development spoke as part of the Flanders Vaccine General Assembly, on Thursday 27th May 2021.

AngloNordic Conferenece
25–26 May 2021
Steven Powell, CEO spoke on the ‘If I knew then what I know now’ panel, on Wednesday 26th May 2021 at 5.15pm CET.

Sachs 7th Immuno-oncology Innovation Forum
18–20 May 2021
Michael Mulqueen, VP of Business Development spoke as part of the ‘Cancer Vaccines, Neo Antigens & Related Modalities’ panel, on Wednesday 19th May 2021 at 8.50am CET.

BioEquity Europe
17–19 May 2021
Steven Powell, CEO spoke at the ‘West-East Roundtable: Next Act Europe-China Collaborations’ panel, on Tuesday 18th May 2021.

  • Volker Germaschewski, Senior VP of R&D, Michael Mulqueen, VP of Business Development, Ulrich Platte, CFO and Tim Van Assche, Director of Business Development & Alliance Management, also attended the conference.
March 10-11, 2021

February 10-11, 2021

October 26-29, 2020

November 9-10, 2020